Australian hyperparallel OCT (HP-OCT) manufacturer Cylite has entered an agreement to integrate the recently launched PreMO myopia app into its...
Read moreDetailsVisioneering Technologies Inc (VTI) has announced positive interim one-year data from the PROTECT clinical trial of its paediatric myopia progression...
Read moreDetailsEyerising International has addressed questions over the safety of its repeated-low level red-Light (RLRL) treatment for myopia management, following two...
Read moreDetailsAt the completion of this article, the reader should have a better understanding of the role of outdoor light exposure...
Read moreDetailsCooperVision’s MiSight 1 day changed the game when it became widely available to Australian practitioners in 2016 for myopia management....
Read moreDetailsManaging myopia in children can be a different ball game in a public-facing clinic, opposed to those in a corporate,...
Read moreDetailsAt the completion of this article, the reader should be able to align their clinical protocols more closely to a...
Read moreDetailsOphthalmic equipment and lens company ZEISS is now offering a complete Kids Portfolio, comprising lenses that cater for the visual...
Read moreDetailsAustralian-owned optical lens and equipment supplier Opticare has two new spectacle lens designs adopting the principle of peripheral retinal defocus...
Read moreDetailsGerman ophthalmic lens manufacturer Rodenstock released its MyCon myopia control spectacle lens into Australia in April this year and...
Read moreDetails
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited